Skip to main content

Non-Small Cell Lung Cancer News (Page 9)

Related terms: Cancer, Lung, Non-Small Cell, Lung Cancer, Non-Small Cell, NSCLC

FDA Approves Gilotrif for Late Stage Non-Small Cell Lung Cancer

July 12, 2013 – The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific...

FDA Approves Abraxane for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer

SUMMIT, N.J.--(BUSINESS WIRE)--Oct 12, 2012 - Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved Abraxane (paclitaxel protein-bound particles for injectable...

FDA Approves Xalkori with Companion Diagnostic for a Type of Late-Stage Lung Cancer

August 26, 2011 - The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers...

FDA Approves Tarceva as a Maintenance Therapy for Advanced Non-Small Cell Lung Cancer

MELVILLE, N.Y., Apr 16, 2010 (BUSINESS WIRE) – OSI Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the daily pill Tarceva (erlotinib) as a maintenance...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Lung Cancer

Related drug support groups

methotrexate, Keytruda, Opdivo